Clinical trial
Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting…
NCT00206635 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00206635 |
|---|---|
| Title | Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis |
| Official title | A Long-term Follow up of Patients Enrolled in the Pivotal Study of Betaseron® (Interferon Beta 1b) in Relapsing-remitting Multiple Sclerosis |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Interferon beta-1b (Betaseron, BAY86-5046) |
| Enrollment | 432 |
| Start date | Jan 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 22, 2012 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: